Company Details
- Employees
- 12
- Founded
- -
- Address
- 33 Irving Pl, New York,10003,united States
- in****@****ica.com
- Industry
- Medical Device
- Website
- oculogica.com
- HQ
- New York
Please complete the CAPTCHA to continue
Related company profiles:
Oculogica Announces Launch of New EyeBOX® Device PR Newswire
FDA OKs New Eye-tracking Concussion Diagnosis Tool American Academy of Family Physicians | AAFP
Microsoft-backed Oculogica Raises $7.6M to Advance Device to Test Concussion citybiz
EyeBOX Test Gets FDA OK to Aid in Concussion Diagnosis Medical Professionals Reference
Oculogica Announces New Category 3 CPT Code Created by American Medical Association GlobeNewswire
How Minnetronix helped Oculogica launch its new EyeBOX concussion diagnostic device Medical Design & Outsourcing
Fund led by Green Bay Packers, Microsoft invests $8 million in Oculogica's concussion assessment technology Green Bay Press-Gazette
Oculogica uses eye-tracking tech for new OcuPro roadside cannabis test Medical Design & Outsourcing
Novel Eye-Tracking Device Offers First Non-Invasive Test to Rapidly Quantify Elevated Intracranial Pressure, a Hallmark of Concussion PR Newswire
4 +191742XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.